----

----

----

----

----

| Cayman Islands                                                 |   | 98-1594916                           |
|----------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization) |   | (I.R.S. Employer Identification No.) |

----

| Title of each class                                                                                               |   | Trading Symbol(s) |   | Name of each exchange on which registered |
|-------------------------------------------------------------------------------------------------------------------|--------|-------------------|--------|-------------------------------------------|
| Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant                       |   | BPACU             |   | The Nasdaq Stock Market LLC               |
| Class A ordinary shares, $0.0001 par value per share                                                              |   | BPAC              |   | The Nasdaq Stock Market LLC               |
| Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 |   | BPACW             |   | The Nasdaq Stock Market LLC               |
| Large accelerated filer | ☐ |   | Accelerated filer         | ☐ |
|-------------------------|---------|--------|---------------------------|---------|
| Non-accelerated filer   | ☒ |   | Smaller reporting company | ☒ |
|                    |    |   | Emerging growth company   | ☒ |

----

----

|                                                 |                                                                                                               | Page   |
|------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|--------|
| Cautionary Note Regarding Forward-Looking Statements | 1                                                                                                                  |
|                                                 | PART I                                                                                                             |   |
| Item 1.                                              | Business                                                                                                           | 2      |
| Item 1A.                                             | Risk Factors                                                                                                       | 11     |
| Item 1B.                                             | Unresolved Staff Comments                                                                                          | 44     |
| Item 2.                                              | Properties                                                                                                         | 44     |
| Item 3.                                              | Legal Proceedings                                                                                                  | 44     |
| Item 4.                                              | Mine Safety Disclosures                                                                                            | 44     |
|                                                 | PART II                                                                                                            |   |
| Item 5.                                              | Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities | 44     |
| Item 6.                                              | [Reserved.]                                                                                                        | 45     |
| Item 7.                                              | Management’s Discussion and Analysis of Financial Condition and Results of Operations                        | 45     |
| Item 7A.                                             | Quantitative and Qualitative Disclosures About Market Risk                                                         | 48     |
| Item 8.                                              | Financial Statements and Supplementary Data                                                                        | 48     |
| Item 9.                                              | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure                               | 48     |
| Item 9A.                                             | Controls and Procedures                                                                                            | 48     |
| Item 9B.                                             | Other Information                                                                                                  | 48     |
| Item 9C.                                             | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections                                                | 48     |
|                                                 | PART III                                                                                                           |   |
| Item 10.                                             | Directors, Executive Officers and Corporate Governance                                                             | 48     |
| Item 11.                                             | Executive Compensation                                                                                             | 51     |
| Item 12.                                             | Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters                     | 51     |
| Item 13.                                             | Certain Relationships and Related Transactions, and Director Independence                                          | 53     |
| Item 14.                                             | Principal Accounting Fees and Services                                                                             | 54     |
|                                                 | PART IV                                                                                                            |   |
| Item 15.                                             | Exhibits, Financial Statement Schedules                                                                            | 55     |
| Item 16.                                             | Form 10-K Summary                                                                                                  | 55     |
|                                                 | EXHIBIT INDEX                                                                                                      |   |
|                                                 | SIGNATURES                                                                                                         |   |
|                                                 | Index to Financial Statements                                                                                      | F-1    |

| • | our ability to select an appropriate target business or businesses; |
|---------|---------------------------------------------------------------------|

| • | our ability to complete our initial business combination; |
|---------|-----------------------------------------------------------|

----

Table of Contents

| • | our expectations around the performance of a prospective target business or businesses; |
|---------|-----------------------------------------------------------------------------------------|

| • | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| • | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| • | our potential ability to obtain additional financing to complete our initial business combination; |
|---------|----------------------------------------------------------------------------------------------------|

| • | our pool of prospective target businesses; |
|---------|--------------------------------------------|

| • | our ability to consummate an initial business combination due to the uncertainty resulting from the recent COVID-19 pandemic; |
|---------|-------------------------------------------------------------------------------------------------------------------------------|

| • | the ability of our officers and directors to generate a number of potential business combination opportunities; |
|---------|-----------------------------------------------------------------------------------------------------------------|

| • | the liquidity and trading of our public securities; |
|---------|-----------------------------------------------------|

| • | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; |
|---------|-------------------------------------------------------------------------------------------------------------------------|

| • | the trust account not being subject to claims of third parties; or |
|---------|--------------------------------------------------------------------|

| • | our financial performance. |
|---------|----------------------------|

| Item 1. | Business. |
|---------|-----------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | solely dependent upon the performance of a single business, property or asset; or |
|--|---------|-----------------------------------------------------------------------------------|
|  | • | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
|--|---------|-----------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|  | • | we issue Class A ordinary shares that will be equal to or in excess of 20% of the number of our Class A ordinary shares then outstanding (other than in a public offering); |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | any of our directors, officers or substantial shareholders (as defined by Nasdaq rules) has a 5% or greater interest (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or assets to              be acquired or otherwise and the present or potential issuance of ordinary shares could result in an increase in outstanding ordinary shares or voting power of 5% or more; or |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | the issuance or potential issuance of ordinary shares will result in our undergoing a change of control. |
|--|---------|----------------------------------------------------------------------------------------------------------|
|  | • | the timing of the transaction, including in the event we determine shareholder approval would require additional time and there is either not enough time to seek shareholder approval or doing so would place the company at a disadvantage in              the transaction or result in other additional burdens on the company; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | the expected cost of holding a shareholder vote; |
|--|---------|--------------------------------------------------|
|  | • | the risk that the shareholders would fail to approve the proposed business combination; |
|--|---------|-----------------------------------------------------------------------------------------|
|  | • | other time and budget constraints of the company; and |
|--|---------|-------------------------------------------------------|
|  | • | additional legal complexities of a proposed business combination that would be time-consuming and burdensome to present to shareholders. |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|   | • | We are a recently incorporated Cayman Islands exempted company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | Past performance by our management team or their respective affiliates may not be indicative of future performance of an investment in us. |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | Our shareholders may not be afforded an opportunity to vote on our proposed initial business combination, which means we may complete our initial business combination even though a majority of our shareholders do not support such a                combination. |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | Your only opportunity to affect the investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | If we seek shareholder approval of our initial business combination, our sponsor and members of our management team have agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote. |
|--------|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with                a target. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure. |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait                for liquidation in order to redeem your shares. |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | The requirement that we consummate an initial business combination within 18 months from the closing of the IPO may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have in                which to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that could produce                value for our shareholders. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by the coronavirus (COVID-19) pandemic and the status of debt and equity                markets. |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | If we seek shareholder approval of our initial business combination, our sponsor, directors, executive officers, advisors and their affiliates may elect to purchase public shares or warrants, which may influence a vote on a proposed                business combination and reduce the public “float” of our Class A ordinary shares or public warrants. |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | If a shareholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed. |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a                loss. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | You will not be entitled to protections normally afforded to investors of many other blank check companies. |
|--------|---------|-------------------------------------------------------------------------------------------------------------|

|   | • | Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we have not consummated our initial business                combination within the required time period, our public shareholders may receive only approximately $10.20 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless. |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | If the net proceeds of the IPO and the sale of the private placement warrants not being held in the trust account are insufficient to allow us to operate for 18 months following the closing of the IPO, it could limit the amount available                to fund our search for a target business or businesses and our ability to complete our initial business combination, and we will depend on loans from our sponsor, its affiliates or members of our management team to fund our search and to                complete our initial business combination. |
|--------|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|   | • | Holders of Class A ordinary shares will not be entitled to vote on any appointment of directors we hold prior to our initial business combination. |
|--------|---------|----------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | The warrants may become exercisable and redeemable for a security other than the Class A ordinary shares, and you will not have any information regarding such other security at this time. |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | Unlike some other similarly structured blank check companies, our sponsor will receive additional Class A ordinary shares if we issue shares to consummate an initial business combination. |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | We may reincorporate in another jurisdiction in connection with our initial business combination and such reincorporation may result in taxes imposed on shareholders or warrant holders. |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | After our initial business combination, it is possible that a majority of our directors and officers will live outside the United States and all of our assets will be located outside the United States; therefore, investors may not be                able to enforce federal securities laws or their other legal rights. |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | Provisions in our amended and restated memorandum and articles of association may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our Class A ordinary shares and could entrench                management. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | Our warrants and private placement warrants are classified as a liability, and we will have to incur significant expense in valuing such liabilities on a quarterly and annual basis. Such liability will be reflected on our financial                statements, and such classification may have an adverse effect on the market price for our Class A ordinary shares or make it more difficult for us to complete an initial business combination. |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Item 1A. | Risk Factors. |
|----------|---------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|   | • | a limited availability of market quotations for our securities; |
|--------|---------|-----------------------------------------------------------------|

|   | • | reduced liquidity for our securities; |
|--------|---------|---------------------------------------|

|   | • | a determination that our Class A ordinary shares are a “penny stock,” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the                secondary trading market for our securities; |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | a limited amount of news and analyst coverage; and |
|--------|---------|----------------------------------------------------|

|   | • | a decreased ability to issue additional securities or obtain additional financing in the future. |
|--------|---------|--------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|   | • | solely dependent upon the performance of a single business, property or asset; or |
|--------|---------|-----------------------------------------------------------------------------------|

|   | • | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

|  | (i) | we issue additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at a Newly Issued Price of less than $9.20 per ordinary share; |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | (ii) | the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the completion of our initial              business combination (net of redemptions); and |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | (iii) | the Market Value is below $9.20 per share, |
|--|-------|--------------------------------------------|

----

Table of Contents

| • | costs and difficulties inherent in managing cross-border business operations; |
|---------|-------------------------------------------------------------------------------|

| • | rules and regulations regarding currency redemption; |
|---------|------------------------------------------------------|

| • | complex corporate withholding taxes on individuals; |
|---------|-----------------------------------------------------|

| • | laws governing the manner in which future business combinations may be effected; |
|---------|----------------------------------------------------------------------------------|

| • | exchange listing and/or delisting requirements; |
|---------|-------------------------------------------------|

| • | tariffs and trade barriers; |
|---------|-----------------------------|

| • | regulations related to customs and import/export matters; |
|---------|-----------------------------------------------------------|

| • | local or regional economic policies and market conditions; |
|---------|------------------------------------------------------------|

| • | unexpected changes in regulatory requirements; |
|---------|------------------------------------------------|

| • | challenges in managing and staffing international operations; |
|---------|---------------------------------------------------------------|

| • | longer payment cycles; |
|---------|------------------------|

| • | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
|---------|--------------------------------------------------------------------------------------------------|

| • | currency fluctuations and exchange controls; |
|---------|----------------------------------------------|

| • | rates of inflation; |
|---------|---------------------|

| • | challenges in collecting accounts receivable; |
|---------|-----------------------------------------------|

| • | cultural and language differences; |
|---------|------------------------------------|

| • | employment regulations; |
|---------|-------------------------|

| • | underdeveloped or unpredictable legal or regulatory systems; |
|---------|--------------------------------------------------------------|

| • | corruption; |
|---------|-------------|

| • | protection of intellectual property; |
|---------|--------------------------------------|

| • | social unrest, crime, strikes, riots, civil disturbances and wars; |
|---------|--------------------------------------------------------------------|

| • | regime changes and political upheaval; and |
|---------|--------------------------------------------|

| • | deterioration of political relations with the United States. |
|---------|--------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

| Item 1B. | Unresolved Staff Comments. |
|----------|----------------------------|

| Item 2. | Properties. |
|---------|-------------|

| Item 3. | Legal Proceedings. |
|---------|--------------------|

| Item 4. | Mine Safety Disclosures. |
|---------|--------------------------|

| Item 5. | Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities. |
|---------|---------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| Item 6. | [Reserved.] |
|---------|-------------|

| Item 7. | Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
|---------|----------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

| Item 7A. | Quantitative and Qualitative Disclosures About Market Risk |
|----------|------------------------------------------------------------|

| Item 8. | Financial Statements and Supplementary Data. |
|---------|----------------------------------------------|

| Item 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. |
|---------|---------------------------------------------------------------------------------------|

| Item 9A. | Controls and Procedures. |
|----------|--------------------------|

| Item 9B. | Other Information. |
|----------|--------------------|

| Item 9C. | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. |
|----------|----------------------------------------------------------------------|

| Item 10. | Directors, Executive Officers and Corporate Governance. |
|----------|---------------------------------------------------------|

| Name            |   | Age |   | Position                 |
|-----------------|--------|-----|--------|--------------------------|
| Paul Martino    |   | 47  |   | Executive Chairman       |
| David VanEgmond |   | 33  |   | Chief Executive Officer  |
| Eric Wiesen     |   | 46  |   | President                |
| Duncan Davidson |   | 69  |   | Executive Vice President |

| Melissa Blau   |   | 53 |   | Director |
|----------------|--------|----|--------|----------|
| Brett Calapp   |   | 46 |   | Director |
| Les Ottolenghi |   | 60 |   | Director |

----

Table of Contents

----

Table of Contents

----

Table of Contents

| Item 11. | Executive Compensation. |
|----------|-------------------------|

| Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters. |
|----------|-------------------------------------------------------------------------------------------------|

----

Table of Contents

|                                              |   | Numberof sharesbeneficially |      |   | Approximatepercentage ofissued andoutstanding |   |
|---------------------------------------------------|--------|-----------------------------|-----------|--------|-----------------------------------------------|--------|
| Name and address of beneficial owner(1)           |   | owned                       |      |   | ordinary shares                               |   |
| BPAC Partners LLC (our Sponsor)(1)                |   |                        | 5,560,250 | (2)(3  | )                                             |   | 22.2 | % |
| David VanEgmond                                   |   |                        | 5,560,250 | (2)(3  | )                                             |   | 22.2 | % |
| Paul Martino                                      |   |                        | 5,560,250 | (2)(3  | )                                             |   | 22.2 | % |
| Eric Wiesen                                       |   |                        | —   |   |                                          |   | — |   |
| Duncan Davidson                                   |   |                        | —   |   |                                          |   | — |   |
| Melissa Blau                                      |   |                        | 28,750    |   |                                          |   | * |   |
| Brett Calapp                                      |   |                        | 28,750    |   |                                          |   | * |   |
| Les Ottolenghi                                    |   |                        | 28,750    |   |                                          |   | * |   |
| All officers and directors as a group (7 persons) |   |                        | 5,645,600 | (2)(3  | )                                             |   | 22.6 | % |

----

|   | * | Less than one percent. |
|--------|---|------------------------|

|   | (1) | Unless otherwise noted, the business address of each of our shareholders is 215 2nd St, Floor 3, San Francisco, CA 94105. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------|

|   | (2) | Interests shown consist solely of founder shares, classified as Class B ordinary shares. Such shares will automatically convert into Class A ordinary shares on a one- for-one basis, subject to adjustment pursuant to certain                      anti-dilution rights, at the time of our initial business combination or earlier at the option of the holders thereof. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (3) | Represents 5,560,250 shares directly held by BPAC Partners LLC. Mr. Martino and Mr. VanEgmond are the two managers of sponsor, and as such share voting and dispositive power over the shares held by sponsor and therefore may be                      deemed to be the beneficial owners of the shares. Each of Mr. Martino and Mr. VanEdgmond disclaims beneficial ownership in excess of his pecuniary interest in such shares. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| Item 13. | Certain Relationships and Related Transactions, and Director Independence. |
|----------|----------------------------------------------------------------------------|

----

Table of Contents

| Item 14. | Principal Accounting Fees and Services. |
|----------|-----------------------------------------|

----

Table of Contents

| Item 15. | Exhibits, Financial Statement Schedules. |
|----------|------------------------------------------|

| ExhibitNumber |   | Description                                                                                                                                                                                                                                                                                                                                                                 |
|---------------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|          |   |                                                                                                                                                                                                                                                                                                                                                                        |
| 1.1           |   | Underwriting Agreement, dated December 2, 2021, by and between the Company and Citigroup Global Markets Inc. (incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K filed with the                    Securities & Exchange Commission on December 2, 2021)                                                                                        |
| 3.1           |   | Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on December 10,                    2021)                                                                                                                                        |
| 4.1           |   | Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to Registration Statement on Form S-1 filed with the Securities & Exchange Commission on November 17, 2021)                                                                                                                                                                                         |
| 4.2           |   | Specimen Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 to Registration Statement on Form S-1 filed with the Securities & Exchange Commission on November 17, 2021)                                                                                                                                                                               |
| 4.3           |   | Specimen Warrant Certificate (included as Exhibit A to Exhibit 4.4)                                                                                                                                                                                                                                                                                                         |
| 4.4           |   | Warrant Agreement, dated December 7, 2021, between the Company and American Stock Transfer & Trust Company, LLC, as warrant agent (incorporated by reference to Exhibit 4.1 to the Current Report on                    Form 8-K filed with the Securities & Exchange Commission on December 7, 2021)                                                               |
| 4.5*          |   | Description of Securities                                                                                                                                                                                                                                                                                                                                                   |
| 10.1          |   | Letter Agreement, dated December 2, 2021, between the Company and the Sponsor (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange                    Commission on December 7, 2021)                                                                                                                      |
| 10.2          |   | Investment Management Trust Agreement, dated December 6, 2021, between the Company and U.S. Bank National Association (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed                    with the Securities & Exchange Commission on December 7, 2021)                                                                              |
| 10.3          |   | Registration Rights Agreement, dated December 7, 2021, among the Company, the Sponsor and certain other security holders named therein (incorporated by reference to Exhibit 10.3 to the Current Report on                    Form 8-K filed with the Securities & Exchange Commission on December 7, 2021)                                                             |
| 10.4          |   | Administrative Services Agreement, dated December 7, 2021, between the Company and the Sponsor (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed with the Securities &                    Exchange Commission on December 7, 2021)                                                                                                     |
| 10.5          |   | Private Placement Warrants Purchase Agreement, dated December 2, 2021, between the Company and the Sponsor (incorporated by reference to Exhibit 10.5 to the Current Report on Form 8-K filed with the                    Securities & Exchange Commission on December 7, 2021)                                                                                         |
| 10.6          |   | Form of Indemnity Agreement, dated December 2, 2021, between the Company and each officer and/or director (incorporated by reference to Exhibit 10.6 to the Current Report on Form 8-K filed with the                    Securities & Exchange Commission on December 7, 2021)                                                                                          |
| 10.8          |   | Securities Subscription Agreement, dated as of April 8, 2021, between the Company and the Sponsor (incorporated by reference to Exhibit 10.8 to Registration Statement on Form S-1 filed with the Securities                    & Exchange Commission on November 17, 2021)                                                                                             |
| 31*           |   | Rule 13a-14(a)/15d-14(a) Certification of the Company’s Principal Executive and Principal Financial Officer.                                                                                                                                                                                                                                                          |
| 32**          |   | Section 1350 Certification of the Company’s Principal Executive and Principal Financial Officer. The information contained in this Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by                    reference in any registration statement filed by the registrant under the Securities Act of 1933, as amended. |
| 99.1*         |   | Audit Committee Charter.                                                                                                                                                                                                                                                                                                                                                    |

----

| Item 16. | Form 10-K Summary |
|----------|-------------------|

----

Table of Contents

|   | BULLPEN PARLAY ACQUISITION COMPANY |
|--------|------------------------------------|
|   | By:                                | /s/ David VanEgmond |
|   |                               | David VanEgmond |
|   |                               | Chief Executive Officer and Director |
|   | Date:                              | March 29, 2022 |
| Signature           |   | Title                                                                                                             |   | Date           |
|---------------------|--------|-------------------------------------------------------------------------------------------------------------------|--------|----------------|
|                |   |                                                                                                              |   |           |
| /s/ David VanEgmond |   | Chief Executive Officer and Director (Principal Executive Officer and Principal Financial and Accounting Officer) |   | March 29, 2022 |
| David VanEgmond     |   |                                                                                                              |   |           |
| /s/ Paul Martino    |   | Executive Chairman and Director                                                                                   |   | March 29, 2022 |
| Paul Martino        |   |                                                                                                              |   |           |
| /s/ Eric Wiesen     |   | President                                                                                                         |   | March 29, 2022 |
| Eric Wiesen         |   |                                                                                                              |   |           |
| /s/ Duncan Davidson |   | Executive Vice President                                                                                          |   | March 29, 2022 |
| Duncan Davidson     |   |                                                                                                              |   |           |
| /s/ Melissa Blau    |   | Director                                                                                                          |   | March 29, 2022 |
| Melissa Blau        |   |                                                                                                              |   |           |
| /s/ Brett Calapp    |   | Director                                                                                                          |   | March 29, 2022 |
| Brett Calapp        |   |                                                                                                              |   |           |
| /s/ Les Ottolenghi  |   | Director                                                                                                          |   | March 29, 2022 |
| Les Ottolenghi      |   |                                                                                                              |   |           |

----

Table of Contents

|                                                                                                                                                                                                    |   |   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|
| ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES                                                                                                                                                        |   | Page   |
| Report of Independent Registered Public Accounting Firm                                                                                                                                                 |   | F-2    |
| Balance Sheet as of December 31, 2021                                                                                                                                                                   |   | F-3    |
| Statement of Operations for the period from April 1, 2021 (inception) through December 31, 2021                                                                                                         |   | F-4    |
| Statement of Changes in Ordinary Shares Subject to Possible Redemption and Stockholder’s Deficit for the period from April 1, 2021 (inception)                          through December 31, 2021 |   | F-5    |
| Statement of Cash Flows for the period from April 1, 2021 (inception) through December 31, 2021                                                                                                         |   | F-6    |
| Notes to Financial Statements                                                                                                                                                                           |   | F-7    |

----

Table of Contents

----

Table of Contents

| ASSETS                                                                                                                                                                                        |   |   |        |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|-------------|
| Cash                                                                                                                                                                                          |   | $      | 2,504,134   |   |
| Prepaid expenses                                                                                                                                                                              |   |   | 617,803     |   |
| Total current assets                                                                                                                                                                          |   |   | 3,121,937   |   |
| Marketable securities held in Trust Account                                                                                                                                                   |   |   | 234,600,000 |   |
| Total Assets                                                                                                                                                                                  |   | $      | 237,721,937 |   |
|                                                                                                                                                                                          |   |   |        |   |
| LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT                                                                                                  |   |   |        |   |
| Current liabilities:                                                                                                                                                                          |   |   |        |   |
| Accounts payable                                                                                                                                                                              |   | $      | 686,125     |   |
| Due to related party                                                                                                                                                                          |   |   | 173,947     |   |
| Accrued expenses                                                                                                                                                                              |   |   | 1,207,573   |   |
| Total current liabilities                                                                                                                                                                     |   |   | 2,067,645   |   |
| Deferred underwriting fees payable                                                                                                                                                            |   |   | 8,050,000   |   |
| Derivative warrant liabilities                                                                                                                                                                |   |   | 15,544,000  |   |
| Total liabilities                                                                                                                                                                             |   |   | 25,661,645  |   |
|                                                                                                                                                                                          |   |   |        |   |
| Commitments and Contingencies (Note 5)                                                                                                                                                        |   |   |        |   |
|                                                                                                                                                                                          |   |   |        |   |
| Class A ordinary shares subject to possible redemption, 23,000,000 shares at $10.20 per share                                                                                                 |   |   | 234,600,000 |   |
|                                                                                                                                                                                          |   |   |        |   |
| Shareholders’ deficit                                                                                                                                                                   |   |   |        |   |
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding                                                                                                |   |   | -           |   |
| Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; none issued and outstanding (excluding 23,000,000 shares subject to                      possible redemption) |   |   | -           |   |
| Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding                                                                             |   |   | 575         |   |
| Additional paid-in capital                                                                                                                                                                    |   |   | -           |   |
| Accumulated deficit                                                                                                                                                                           |   |   | (22,540,283 | ) |
| Total shareholders’ deficit                                                                                                                                                             |   |   | (22,539,708 | ) |
| Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit                                                                                            |   | $      | 237,721,937 |   |

----

Table of Contents

|                                                                                                             |   | For The Period From April 01, 2021 (Inception)Through December 31, 2021 |      |
|------------------------------------------------------------------------------------------------------------------|--------|-------------------------------------------------------------------------|-----------|
|                                                                                                             |   |                                                                    |      |
| Formation and operating costs                                                                                    |   | $                                                                       | 382,412   |   |
| Loss from operations                                                                                             |   |                                                                    | (382,412  | ) |
| Change in fair value of derivative warrant liabilities                                                           |   |                                                                    | 464,000   |   |
| Transaction costs allocation to derivative warrant liabilities                                                   |   |                                                                    | (473,807  | ) |
| Compensation expense                                                                                             |   |                                                                    | (454,005  | ) |
| Net loss                                                                                                         |   | $                                                                       | (846,224  | ) |
| Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted |   |                                                                    | 2,145,522 |   |
| Basic and diluted net loss per share, Class A  subject to possible redemption                               |   | $                                                                       | (0.12     | ) |
| Weighted average shares outstanding of Class B non-redeemable ordinary shares, basic and diluted                 |   |                                                                    | 5,069,963 |   |
| Basic and diluted net loss per share, Class B non-redeemable ordinary shares                                     |   | $                                                                       | (0.12     | ) |

----

Table of Contents

|                                                               |   | Ordinary Shares Subject to Possible Redemption |       |   | Ordinary Shares |   |        |   |   |   |      |   |   |                                             |   |
|--------------------------------------------------------------------|--------|------------------------------------------------|------------|--------|-----------------|--------|-------------|--------|--------|--------|-----------|--------|--------|--------------------------------------------------|--------|
|                                                               |   | Class A                                        |       |   | Class B         |   |        |   |   |   |      |   |   |                                             |   |
|                                                               |   | Shares                                         |       |   | Amount          |   |        | Shares |   |   | Amount    |   |   | Additional Paid-In                       Capital |   |   | AccumulatedDeficit |   |   | Total Shareholders’ Deficit |   |
| Balance as of April 01, 2021                                       |   |                                           | -          |   |            | $      | -           |   |   |   | -         |   |   | $                                                | -      |   |   | $ | - |   |   | $ | - |   |   | $ | - |   |
| Issuance of ordinary shares to Sponsor                             |   |                                           | -          |   |            |   | -           |   |   |   | 5,750,000 |   |   |                                             | 575    |   |   |   | 24,425 |   |   |   | - |   |   |   | 25,000 |   |
| Proceeds from the sale of Class A ordinary shares                  |   |                                           | 23,000,000 |   |            |   | 230,000,000 |   |   |   | -         |   |   |                                             | -      |   |   |   | - |   |   |   | - |   |   |   | - |   |
| Paid underwriters fees                                             |   |                                           | -          |   |            |   | (4,600,000  | )      |   |   | -         |   |   |                                             | -      |   |   |   | - |   |   |   | - |   |   |   | - |   |
| Deferred underwriting fees payable                                 |   |                                           | -          |   |            |   | (8,050,000  | )      |   |   | -         |   |   |                                             | -      |   |   |   | - |   |   |   | - |   |   |   | - |   |
| Liabilities associated to equity instruments - Public Warrants     |   |                                           | -          |   |            |   | (7,935,000  | )      |   |   | -         |   |   |                                             | -      |   |   |   | - |   |   |   | - |   |   |   | - |   |
| Other offering costs                                               |   |                                           | -          |   |            |   | (614,489    | )      |   |   | -         |   |   |                                             | -      |   |   |   | - |   |   |   | - |   |   |   | - |   |
| Shared based compensation to directors                             |   |                                           | -          |   |            |   | -           |   |   |   | -         |   |   |                                             | -      |   |   |   | 454,005 |   |   |   | - |   |   |   | 454,005 |   |
| Excess cash received over fair value of Private Placement Warrants |   |                                           | -          |   |            |   | -           |   |   |   | -         |   |   |                                             | -      |   |   |   | 3,627,000 |   |   |   | - |   |   |   | 3,627,000 |   |
| Accretion of Class A ordinary shares to redemption value           |   |                                           | -          |   |            |   | 25,799,489  |   |   |   | -         |   |   |                                             | -      |   |   |   | (4,105,430 | ) |   |   | (21,694,059 | ) |   |   | (25,799,489 | ) |
| Net loss                                                           |   |                                           | -          |   |            |   | -           |   |   |   | -         |   |   |                                             | -      |   |   |   | - |   |   |   | (846,224 | ) |   |   | (846,224 | ) |
| Balance as of December 31, 2021                                    |   |                                           | 23,000,000 |   |            | $      | 234,600,000 |   |   |   | 5,750,000 |   |   | $                                                | 575    |   |   | $ | - |   |   | $ | (22,540,283 | ) |   | $ | (22,539,708 | ) |

----

Table of Contents

|                                                                        |   |  For The Period From April 01, 2021 (Inception)Through December 31, 2021 |         |
|-----------------------------------------------------------------------------|--------|-------------------------------------------------------------------------------|--------------|
| Cash Flows from Operating Activities                                        |   |                                                                          |         |
| Net Loss                                                                    |   | $                                                                             | (846,224     | ) |
| Adjustments to reconcile net loss to net cash used in operating activities: |   |                                                                          |         |   |
| Compensation expense                                                        |   |                                                                          | 454,005      |   |
| Transaction costs allocated to derivative warrant liabilities               |   |                                                                          | 473,807      |   |
| Formation and operating expenses funded by note payable through Sponsor     |   |                                                                          | 10,926       |   |
| Change in fair value of derivative warrant liabilities                      |   |                                                                          | (464,000     | ) |
| Formation and operating expenses paid in exchange for Founder Shares        |   |                                                                          | 18,941       |   |
| Changes in operating assets and liabilities:                                |   |                                                                          |         |   |
| Prepaid and other assets                                                    |   |                                                                          | (617,803     | ) |
| Accounts payable                                                            |   |                                                                          | 671,125      |   |
| Accrued expenses                                                            |   |                                                                          | 298,857      |   |
| Net cash used by operating activities                                       |   |                                                                          | (366         | ) |
| Cash Flows from Investing Activities                                        |   |                                                                          |         |   |
| Investment of cash into Trust Account                                       |   |                                                                          | (234,600,000 | ) |
| Net cash provided by investing activities                                   |   |                                                                          | (234,600,000 | ) |
| Cash Flows from Financing Activities                                        |   |                                                                          |         |   |
| Proceeds from note payable and advances from related party                  |   |                                                                          | 4,500        |   |
| Proceeds from sale of Class A shares, gross                                 |   |                                                                          | 230,000,000  |   |
| Proceeds from sale of Private Placement Warrants                            |   |                                                                          | 11,700,000   |   |
| Offering costs paid                                                         |   |                                                                          | (4,600,000   | ) |
| Net cash provided by financing activities                                   |   |                                                                          | 237,104,500  |   |
|                                                                        |   |                                                                          |         |   |
| Net increase in cash                                                        |   |                                                                          | 2,504,134    |   |
| Cash - beginning of period                                                  |   |                                                                          | -            |   |
| Cash - end of period                                                        |   | $                                                                             | 2,504,134    |   |
|                                                                        |   |                                                                          |         |   |
| Supplemental disclosure of noncash investing and financing activities:      |   |                                                                          |         |   |
| Initial class A shares subject to possible redemption                       |   | $                                                                             | 209,254,516  |   |
| Immediate accretion of Class A shares to redemption value                   |   | $                                                                             | 25,345,484   |   |
| Offering costs included in accounts payable                                 |   | $                                                                             | 15,000       |   |
| Offering costs included in accrued expenses                                 |   | $                                                                             | 908,716      |   |
| Offering costs paid through promissory note - related party                 |   | $                                                                             | 158,521      |   |
| Offering costs paid through prepaid legal expense funded by sponsor         |   | $                                                                             | 6,059        |   |
| Deferred underwriting fees payable                                          |   | $                                                                             | 8,050,000    |   |

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|   | • | Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; |
|--------|---------|----------------------------------------------------------------------------------------------------------|

|   | • | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices                      for identical or similar instruments in markets that are not active; and |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in                      which one or more significant inputs or significant value drivers are unobservable. |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| Gross proceeds                                         |   | $      | 230,000,000 |   |
|--------------------------------------------------------|--------|--------|-------------|--------|
| Less:                                                  |   |   |        |   |
| Class A ordinary shares issuance costs                 |   |   | (13,264,489 | )      |
| Fair value of Public Warrants at issuance              |   |   | (7,935,000  | )      |
|                                                   |   |   |        |   |
| Plus:                                                  |   |   |        |   |
| Accretion of carrying value to redemption value        |   |   | 25,799,489  |   |
| Class A ordinary shares subject to possible redemption |   | $      | 234,600,000 |   |

----

Table of Contents

|                                                                                |   | For The Period From April 01, 2021 (Inception) Through December 31, 2021 |      |
|-------------------------------------------------------------------------------------|--------|--------------------------------------------------------------------------|-----------|
| Redeemable Class A Ordinary Shares                                                  |   |                                                                     |      |
| Numerator: Net income allocable to Redeemable Class A Ordinary Shares               |   | $                                                                        | (251,624  | ) |
|                                                                                |   |                                                                     |      |   |
| Denominator: Weighted Average Share Outstanding, Redeemable Class A Ordinary Shares |   |                                                                     |      |   |
| Basic and diluted weighted average shares outstanding, Redeemable Class A           |   |                                                                     | 2,145,522 |   |
| Basic and diluted net earnings per share, Redeemable Class A                        |   | $                                                                        | (0.12     | ) |
|                                                                                |   |                                                                     |      |   |
| Non-Redeemable Class B Ordinary Shares                                              |   |                                                                     |      |   |
| Numerator: Net income allocable to non-redeemable Class B Ordinary Shares           |   |                                                                     |      |   |
| Net income allocable to non-redeemable Class B Ordinary Shares                      |   | $                                                                        | (594,600  | ) |
|                                                                                |   |                                                                     |      |   |
| Denominator: Weighted Average Non-Redeemable Class B Ordinary Shares                |   |                                                                     | 5,069,963 |   |
| Basic and diluted weighted average shares outstanding, Non-Redeemable Class B       |   | $                                                                        | (0.12     | ) |

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|   | • | in whole and not in part; |
|--------|---------|---------------------------|

|   | • | at a price of $0.01 per warrant; |
|--------|---------|----------------------------------|

|   | • | upon a minimum of 30 days’ prior written notice of redemption; and |
|--------|---------|--------------------------------------------------------------------------|

|   | • | if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon                      exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Warrants — Redemption Procedures — Anti-dilution Adjustments”) for any 20 trading days within a 30-trading day                      period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders. |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | in whole and not in part; |
|--------|---------|---------------------------|

|   | • | at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and                      receive that number of shares determined by reference to the table set forth under “Description of Securities — Warrants — Public Warrants” based on the redemption date and the “fair market value” of Class A ordinary shares (as                      defined below) except as otherwise described in “Description of Securities — Warrants — Public Warrants”; |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price                      of a warrant as described under the heading “Description of Securities — Warrants — Public Warrants — Redemption Procedures — Anti-dilution Adjustments”) for any 20 trading days within the 30-trading day period ending three trading                      days before we send the notice of redemption to the warrant holders; and |
|--------|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to                      the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants —                      Public Warrants — Redemption Procedures — Anti-dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|                                |   | Level 1 |        |   | Level 2 |   |   | Level 3 |   |
|-------------------------------------|--------|---------|-------------|--------|---------|--------|--------|---------|--------|
| Assets:                             |   |    |        |   |    |   |   |    |   |
| Marketable securities held in trust |   | $       | 234,600,000 |   |    | $      | -      |    |   | $ | - |   |
| Liabilities:                        |   |    |        |   |    |   |   |    |   |   |   |   |
| Public Warrants                     |   | $       | -           |   |    | $      | -      |    |   | $ | 7,705,000 |   |
| Private Placement Warrants          |   |    | -           |   |    |   | -      |    |   |   | 7,839,000 |   |
| Total liabilities                   |   | $       | -           |   |    | $      | -      |    |   | $ | 15,544,000 |   |

----

Table of Contents

| As of December 31, 2021            |   |   |   |
|------------------------------------|--------|--------|--------|
| Volatility                         |   |   | 11.0   | % |
| Underlying stock price             |   | $      | 9.67   |   |
| Expected time until merger (years) |   |   | 5.92   |   |
| Risk-free rate                     |   |   | 1.33   | % |
| Dividend yield                     |   |   | 0.0    | % |
| Derivative warrant liabilities at April 1, 2021 (inception)                |   | $      | —    |   |
|----------------------------------------------------------------------------|--------|--------|------------|--------|
| Issuance of Public and Private Warrants - Level 3 measurements             |   |   | 16,008,000 |   |
| Change in fair value of derivative warrant liabilities with Level 3 inputs |   |   | (464,000   | )      |
| Derivative warrant liabilities at December 31, 2021 with Level 3 inputs    |   | $      | 15,544,000 |   |

----